Nasdaq: PBM/Biotechnology
Psyence Biomedical Ltd.
Toronto, ON, Canada
Company overview
Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.
This profile is for informational purposes only and is not investment advice. Company information may change after the verification date.